• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Medtronic facing class action suit from Canada MiniMed insulin pump users

October 28, 2021 By Sean Whooley

Medtronic Minimed 630g
Medtronic’s MiniMed 630G insulin pump [Image courtesy of Medtronic]
A national class action in Canada has been commenced against Medtronic (NYSE:MDT) over its MiniMed 630G and 670G insulin pumps.

Rochon Genova and Cardill Law commenced the proposed class action suit against Medtronic, Medtronic MiniMed and Medtronic of Canada over the insulin pumps approved for use in the country in 2016 and 2018. The pumps have become subject to some issues, with the most recent coming in the form of an expansion of an FDA Class I recall that resulted in 463,464 devices being recalled.

For the same issue — missing or broken retainer rings that could result in the over- or under-delivery of insulin — Health Canada issued a Type II Medical Device Recall in 2019, then a Type 1 recall earlier this month, according to a news release.

The proposed class action alleges that Medtronic knew or ought to have known that the devices were suffering from a defective retainer ring but failed to take the steps to address it or offer warnings to users until the devices had been on the market for several years and were in use by thousands of Canadians.

“Canadians have a right to be informed about the risks associated with the medical devices that they use,” Rochon Genova partner Joel Rochon said in the release. “Failure to provide adequate warnings can have serious consequences. In this case, the plaintiffs needlessly suffered severe hyperglycemia requiring hospitalization.”

The claims have not yet been proven in court.

Medtronic did not offer direct comment on the class action suit but referred to its Oct. 5 news release covering the issue with the MiniMed 600 series devices.

That news release said that the review of safety data related to the MiniMed 600 series insulin pumps with clear retainer rings has not confirmed that adverse events were directly related to the damaged clear retainer rings, but that the company is “proactively accelerating our replacement plan so we can strive for the greatest possible reliability and quality in our insulin pumps and help patients optimally manage their diabetes.”

“Insulin pumps are sophisticated medical technologies that work to normalize blood glucose levels as much as possible in individuals with diabetes who don’t have the ability to produce insulin naturally,” Medtronic Diabetes CMO Dr. Robert Vigersky said in the release. “As with all therapies, there are risks that should be considered when a patient and their healthcare provider decide to use a pump for insulin delivery rather than multiple daily injections. The totality of evidence from both controlled, large scale clinical trials and real-world studies strongly support the safety and benefits of insulin pump therapies.”

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Legal News, Recalls Tagged With: Medtronic

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS